The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMID 11910610)

Published in Climacteric on March 01, 2000

Authors

H P Schneider1, L A Heinemann, H P Rosemeier, P Potthoff, H M Behre

Author Affiliations

1: Department of Obstetrics and Gynecology, University of Muenster, Albert-Schweitzer-Str. 33, D-48129 Muenster, Germany.

Articles citing this

International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes (2003) 1.70

The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes (2004) 1.62

The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes (2004) 1.03

Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women. Patient Prefer Adherence (2013) 0.88

Suan zao ren tang as an original treatment for sleep difficulty in climacteric women: a prospective clinical observation. Evid Based Complement Alternat Med (2011) 0.87

Effect of acupuncture on premature ovarian failure: a pilot study. Evid Based Complement Alternat Med (2014) 0.82

Poor sleep in middle-aged women is not associated with menopause per se. Braz J Med Biol Res (2016) 0.81

Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial. Obstet Gynecol (2015) 0.80

Alternative supplement for enhancement of reproductive health and metabolic profile among perimenopausal women: a novel role of Nigella sativa. Iran J Basic Med Sci (2014) 0.80

Use acupuncture to relieve perimenopausal syndrome: study protocol of a randomized controlled trial. Trials (2014) 0.76

Dose-Dependent Effects of the Cimicifuga racemosa Extract Ze 450 in the Treatment of Climacteric Complaints: A Randomized, Placebo-Controlled Study. Evid Based Complement Alternat Med (2012) 0.75

Bee pollen and honey for the alleviation of hot flushes and other menopausal symptoms in breast cancer patients. Mol Clin Oncol (2015) 0.75

Quality of life and hormone use: new validation results of MRS scale. Health Qual Life Outcomes (2006) 0.75

The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause. Fam Cancer (2012) 0.75

Effect of acupuncture on hot flush and menopause symptoms in breast cancer- A systematic review and meta-analysis. PLoS One (2017) 0.75

What Sexual Behaviors Relate to Decreased Sexual Desire in Women? A Review and Proposal for End Points in Treatment Trials for Hypoactive Sexual Desire Disorder. Sex Med (2016) 0.75

Articles by these authors

Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ (1996) 6.16

Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int (2000) 3.86

Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women. Contraception (1996) 3.23

Lifespan and testosterone. Nature (1993) 2.84

Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male (2005) 2.60

Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ (1996) 2.49

Creatine kinase activity in human spermatozoa and seminal plasma lacks predictive value for male fertility in in vitro fertilization. Fertil Steril (1998) 1.98

The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. Climacteric (2000) 1.91

The differential risk of oral contraceptives: the impact of full exposure history. Hum Reprod (1999) 1.78

External quality control in the andrology laboratory: an experimental multicenter trial. Fertil Steril (1990) 1.65

Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab (2000) 1.60

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol (2008) 1.55

Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol (1996) 1.53

[The Menopause Rating Scale (MRS II): methodological standardization in the German population]. Zentralbl Gynakol (2000) 1.46

Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril (1995) 1.45

[The Kallmann syndrome. Its pathophysiology and clinical picture]. Dtsch Med Wochenschr (1994) 1.39

Testosterone replacement therapy: current trends and future directions. Hum Reprod Update (2004) 1.33

[Reliability of the Menopause Rating Scale (MRS): Investigation in the German population]. Zentralbl Gynakol (2002) 1.32

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl (2008) 1.31

The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Contraception (1997) 1.30

Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study of Climen. Maturitas (2000) 1.29

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl (2006) 1.26

ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res (2008) 1.22

Mobile phone base stations and adverse health effects: phase 1 of a population-based, cross-sectional study in Germany. Occup Environ Med (2008) 1.14

Mobile phone base stations and adverse health effects: phase 2 of a cross-sectional study with measured radio frequency electromagnetic fields. Occup Environ Med (2009) 1.14

Harmonized French version of the Aging Males' Symptoms Scale. Aging Male (2003) 1.14

Serum FSH and testicular morphology in male infertility. Clin Endocrinol (Oxf) (1994) 1.05

Screening for deletions of the Y chromosome involving the DAZ (Deleted in AZoospermia) gene in azoospermia and severe oligozoospermia. Fertil Steril (1997) 1.05

Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol (2005) 1.04

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl (2005) 1.03

Chromosome abnormalities in 447 couples undergoing intracytoplasmic sperm injection--prevalence, types, sex distribution and reproductive relevance. Hum Reprod (1998) 1.01

Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene (2006) 0.98

Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J (1998) 0.97

Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol (1998) 0.97

Update on treatment of varicocele: counselling as effective as occlusion of the vena spermatica. Hum Reprod (1998) 0.97

Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol (1996) 0.95

Investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Androl (2008) 0.94

Surgical ligation vs. angiographic embolization of the vena spermatica: a prospective randomized study for the treatment of varicocele-related infertility. Andrologia (1993) 0.94

Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a). J Clin Endocrinol Metab (1997) 0.92

Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men. Clin Endocrinol (Oxf) (1999) 0.92

Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignancies. Hum Reprod (1997) 0.90

Correlations between hormones, physical, and affective parameters in aging urologic outpatients. Eur Urol (2005) 0.89

Reversion of the differentiated phenotype and maturation block in Sertoli cells in pathological human testis. Hum Reprod (1999) 0.88

Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications. Oncogene (2006) 0.86

Frequently subnormal semen profiles of normal volunteers recruited over 17 years. Int J Androl (1997) 0.86

CFTR gene mutations in men with bilateral ejaculatory-duct obstruction and anomalies of the seminal vesicles. Am J Hum Genet (1997) 0.86

Reproductive parameters of older compared to younger men of infertile couples. Int J Androl (1996) 0.85

Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad link. Leukemia (2006) 0.85

[Data evaluation in the German Health Survey]. Gesundheitswesen (1998) 0.85

Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, testicular size, and serum inhibin levels in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis). Endocrinology (1991) 0.85

Pharmacokinetics and pharmacodynamics of testosterone enanthate and dihydrotestosterone enanthate in non-human primates. Acta Endocrinol (Copenh) (1990) 0.85

Atherosclerosis in apolipoprotein E-deficient mice is decreased by the suppression of endogenous sex hormones. Horm Metab Res (2001) 0.84

Low-level sex chromosome mosaicism in female partners of couples undergoing ICSI therapy does not significantly affect treatment outcome. Hum Reprod (2001) 0.84

Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception. J Clin Endocrinol Metab (1999) 0.84

Lack of correlation between cadmium in seminal plasma and fertility status of nonexposed individuals and two cadmium-exposed patients. Reprod Toxicol (1996) 0.84

Clustering of male infertility in the families of couples treated with intracytoplasmic sperm injection. Hum Reprod (2000) 0.83

Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. Eur J Endocrinol (1998) 0.83

Transmission of a Y chromosomal deletion involving the deleted in azoospermia (DAZ) and chromodomain (CDY1) genes from father to son through intracytoplasmic sperm injection: case report. Hum Reprod (1999) 0.83

High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. Eur J Endocrinol (1994) 0.83

A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: monitoring of testosterone replacement therapy with testosterone buciclate. Clin Chem Lab Med (1998) 0.82

[Fertility in patients with Klinefelter syndrome (47,XXY)]. Urologe A (2011) 0.82

Restoration of spermatogenesis by follicle-stimulating hormone despite low intratesticular testosterone in photoinhibited hypogonadotropic Djungarian hamsters (Phodopus sungorus). Biol Reprod (1993) 0.82

Do caffeine-containing analgesics promote dependence? A review and evaluation. Clin Pharmacol Ther (2000) 0.82

[The Bavarian Thromboembolic Risk Cohort Study (BATER). Study protocol, state of the investigation and first results]. Dtsch Med Wochenschr (2000) 0.82

Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism? Eur J Contracept Reprod Health Care (2000) 0.81

Endocrine control of testicular somatic and premeiotic germ cell development in the immature testis of the primate Macaca mulatta. Eur J Endocrinol (1995) 0.80

The gonadotropin-releasing hormone (GnRH) agonist-induced initial rise of bioactive LH and testosterone can be blunted in a dose-dependent manner by GnRH antagonist in the non-human primate. Urol Res (1992) 0.80

Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod (1998) 0.80

Pharmacokinetics of new testosterone transdermal therapeutic systems in gonadotropin-releasing hormone antagonist-suppressed normal men. Exp Clin Endocrinol Diabetes (1999) 0.80

Treatment of varicocele: counselling as effective as occlusion of the vena spermatica. Hum Reprod (1995) 0.79

Occupational exposure and liver cancer in women: results of the Multicentre International Liver Tumour Study (MILTS). Occup Med (Lond) (2000) 0.79

Alteration of Sertoli cell differentiation in the presence of carcinoma in situ in human testes. J Urol (1998) 0.79

Testosterone treatment of hypogonadal men participating in competitive sports. Andrologia (2008) 0.79

Diagnostic value of scrotal sonography in infertile men: report on 658 cases. Andrologia (1991) 0.79

DNA flow cytometry of human semen. Hum Reprod (1999) 0.79

Peroxidase-positive round cells and microorganisms in human semen together with antibiotic treatment adversely influence the outcome of in-vitro fertilization and embryo transfer. Int J Androl (1994) 0.78

Multicentre international liver tumour study protocol of the case-control study on hepatocellular cancer. Pharmacoepidemiol Drug Saf (1996) 0.78

Duration of the cycle of the seminiferous epithelium, estimated by the 5-bromodeoxyuridine technique, in laboratory and feral rats. J Reprod Fertil (1994) 0.78

Cost containment in a statutory health insurance scheme by substitution of outpatient for inpatient care? The case of the Bavarian Contract. Health Policy (1987) 0.78

Predictors of early retirement and rehabilitation for use in a screening to detect workers in need of rehabilitation. Int J Rehabil Res (1998) 0.77

Round spermatids from infertile men exhibit decreased protamine-1 and -2 mRNA. Hum Reprod (2001) 0.77

Growth retardation, testicular stimulation, and increased melatonin synthesis by weak magnetic fields (50 Hz) in Djungarian hamsters, Phodopus sungorus. Biochem Biophys Res Commun (1997) 0.77

Comparative effects of chronic administration of the non-steroidal antiandrogens flutamide and Casodex on the reproductive system of the adult male rat. Acta Endocrinol (Copenh) (1991) 0.77

Effects of testosterone suppression in young men by the gonadotropin releasing hormone antagonist cetrorelix on plasma lipids, lipolytic enzymes, lipid transfer proteins, insulin, and leptin. Exp Clin Endocrinol Diabetes (1999) 0.77

Lowered risk of dying of heart attack with third generation pill may offset risk of dying of thromboembolism. BMJ (1997) 0.76

Endocrine and spermatological characteristics of 135 patients with bilateral megalotestis. Andrologia (1995) 0.76

Influence of sperm surface antibodies on spontaneous pregnancy rates. Fertil Steril (1998) 0.76

Venous thromboembolism and oral contraceptives. Lancet (1999) 0.75

Ineffectiveness of kallikrein in treatment of idiopathic male infertility: a double-blind, randomized, placebo-controlled trial. Hum Reprod (1994) 0.75

Scientific problems with a noncausal artifact. Am J Obstet Gynecol (1998) 0.75

Potency differences in GnRH antagonists? Fertil Steril (1994) 0.75

Oral contraceptives and venous thromboembolism. Lancet (1997) 0.75

Oral contraceptives and venous thromboembolism: acquired APC resistance? Br J Haematol (1997) 0.75

Can testosterone alone maintain the gonadotrophin-releasing hormone antagonist-induced suppression of spermatogenesis in the non-human primate? J Endocrinol (1994) 0.75